RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 1967; 18(01/02): 012-023
DOI: 10.1055/s-0038-1655013
DOI: 10.1055/s-0038-1655013
Originalarbeiten — Original Articles — Travaux Originaux
A Distinction between the Role of Precursor and Activated Forms of Clotting Factors in the Genesis of Stasis Thrombi[*]
This work was supported by Research Grant HE 09326 from the National Institutes of Health, U.S. Public Health Service.The authors wish to acknowledge the technical assistance of Mrs. Alberta F. Bailey and Mr. Milton H. Lipsky.
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
26. Juni 2018 (online)
Summary
1. In vivo studies in rabbits have shown that the liver diminishes the thrombo-genicity of infused human serum.
2. In vitro rabbit liver perfusions with human serum have demonstrated the loss of serum thrombogenicity within 5 min after the onset of the perfusion. Associated with this loss of thrombotic capacity is a marked decrease in the activation product (AP) and labile factor IX (PPA) activity in the infused serum.
3. The liver appears to have the capacity to discriminate between circulating activated clotting activities such as AP and PPA and inactive procoagulants such as stable or genuine factor IX, factor VII and factor X. The latter are not cleared from the circulation by the liver.
4. These studies provide some insight into the mechanism whereby circulating activated clotting activities and retarded blood flow predispose to thrombosis.
* Presented in part at the International Symposium on the Pathogenesis and Treatment of Thromboembolic Diseases, Basel, Switzerland, August, 1965.
-
References
- 1 Alkjaersig N, Fletcher A. P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest 38: 1086-1095 1959;
- 2 Bachmann F, Duckert F, Koller F. The Stuart-Power factor assay and its clinical significance. Thrombos. Diathes. haemorrh. (Stuttg) 02: 24 1958;
- 3 Baumgarten P. Die sogenannte Organization des Thrombus. Otto Wigand. Leipzig: 1877
- 4 Best C. H, Taylor N. B. In: Documenta Geigy scientific tables. 5th ed.. 124 Basel: 1959
- 5 Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. 3rd Ed.,. 378 F.A. Davis Co; Philadelphia: 1962
- 6 Deykin D. The role of the liver in serum-induced hypercoagulability. J. clin. Invest 45: 256 1966;
- 7 Deykin D, Wessler S. Activation product, factor IX, serum thrombotic accelerator activity, and serum-induced thrombosis. J. clin. Invest 43: 160 1964;
- 8 Duckert F. The prephase accelerator. Present status. Thrombos. Diathes. haemorrh. (Stuttg) 05: 254 1961;
- 9 Duckert F. Factor IX. Function and kinetics. In: The Hemophilias. 177 Brinkhous K. M. (Ed.) The University of North Carolina Press; 1964
- 10 Duckert F, Yin E. T, Straub W. Separation and purification of the blood clotting factors by means of chromatography and electrophoresis. Preparative methods. VIII Colloquium. Pro-tides of biological fluids. Sint-Janshospital. Brugge, Belgium; May 1960
- 11 Fisch U. Über einen neuen Accelerator der Blutthrombokinasebildung. Thrombos. Diathes. haemorrh (Stuttg) 02: 60 1958;
- 12 Fisch U, Duckert F. Some aspects of kinetics of the first stages of blood thromboplastin formation. Thrombos. Diathes. haemorrh. (Stuttg) 03: 98 1959;
- 13 Gaebler O. H. Determination of bromsulphalein in normal turbid, hemolyzed, or icteric serum. Amer. J. clin. Path. 15: 452 1945;
- 14 Geiger M, Duckert F, Koller F. Quantitative Bestimmungen von Faktor VIII (Anti-hamophiles Globulin) und Faktor IX (Christmas factor, PTC) bei Blutersippen. 5th Congr. Eur op. Soc. Haemat. Springer, Heidelberg: 1956
- 15 Glenard F. Contribution a l’etude des causes de la coagulation spontanee du sang a son issue de l’organisme, application a la transfusion. Paris theses, No. 46. 1875
- 16 Gornall A. G, Bardawill C. J, David M. N. Determination of serum proteins by means of the biuret reaction. J. biol. Chem. 177: 751 1949;
- 17 Hewson W. Experimental inquires. I. An inquiry into the properties of the blood, with some remarks on some of its morbid appearances; and an appendix relating to the discovery of the lymphatic system in birds, fish, and the animals called amphibians. T. Cadell. London: 1771
- 18 Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand. J. clin. Lab. Invest 09 (Suppl. 27): 1 1957;
- 19 Koller F, Baer P, Geiger M. Über die Auslösung des Gerinnungsvorganges. Acta haemat. (Basel) 18: 33 1957;
- 20 Lister J. The Croonian lecture on the coagulation of the blood. Lancet II: 149 1863;
- 21 McLachlin A. D, McLachlin J. A, Jory T. A, Rawling E. G. Venous stasis in the lower extremities. Ann. Surg. 152: 678 1960;
- 22 Proctor R. R, Rapaport S. I. The partial thromboplastin time with kaolin. Amer. J. clin. Path. 36: 212 1961;
- 23 Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer. J. clin. Path. 28: 56 1957;
- 24 Spaet T. H. Studies on the in vivo behavior of blood coagulation product I in rats. Thrombos. Diathes. haemorrh. (Stuttg) 08: 276 1962;
- 25 Spaet T. H, Kropatkin M. Effect of intravenous soy bean phosphatides on blood coagulation in rabbits. Proc. Soc. exp. Biol. (N. Y) 95: 492 1957;
- 26 Stanton J. R, Freis E. D, Wilkins R. W. The acceleration of linear flow in the deep veins of the lower extremity of man by local compression. J. clin. Invest 28: 553 1949;
- 27 Stocker H, Yin E. T, Duckert F. Neue Beobachtungen bei einer hamorrhagischen Diathese. Schweiz. med. Wschr. Nr. 43: 1365 1962;
- 28 Straub W. Separation of coagulation factors by means of starch gel electrophoresis. Thrombos. Diathes. haemorrh. (Stuttg) 04: 451 1960;
- 29 Waaler B. A. Contact activation in the intrinsic blood clotting system. Scand. J. clin. Lab. Invest 11 (Suppl. 37): 01 1959;
- 30 Wessler S. Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J. clin. Invest 34: 647 1955;
- 31 Wessler S, Reiner L, Freiman D. G, Reimer S. M, Lertzman M. Serum-induced thrombosis. Studies of it’s induction and evolution under controlled conditions in vivo. Circulation 20: 864 1959;
- 32 Wessler S, Reimer S. M, Sheps M. C. Biologic assay of a thrombosis-inducing activity in human serum. J. appl. Physiol. 14: 943 1959;
- 33 Yin E. T. Kinetics of human blood coagulation induced by trypsin. Thrombos. Diathes. haemorrh. (Stuttg) 12: 307 1964;
- 34 Yin E. T, Duckert F. Formation of intermediate product I in purified system: The role of factor IX or its precursor and of Hageman-PTA fraction. Thrombos. Diathes. haemorrh. (Stuttg) 06: 224 1961;
- 35 Yin E. T, Duckert F. Purification of factor IX or of its precursor. Isolation of a Hageman-PTA fraction. Thrombos. Diathes. haemorrh. (Stuttg) 06: 215 1961;